Clinical trial Recruiting at 1 site Interventional Ages 15 to 20

Digital program to help teenagers transition from pediatric to adult healthcare

Official title: Evaluation of the Digital Delivery of Person-centered Transitional Care to Empower Adolescents With Chronic Childhood-onset Diseases: The Digi-STEPSTONES Study

Run by Göteborg University · NCT06823622 · Data updated 2026-11-12

This study is testing a new online program to help teenagers with asthma and organ transplants smoothly move from children's to adult healthcare and see if it works better than regular in-person care.

More Asthma in Children trials

Quick facts

Study typeInterventional
Ages15 Years to 20 Years
SexAll
Enrollment100 (estimated)
SponsorGöteborg University
Academic / other
Locations2 sites (Gothenburg, Vastra Gotalandsregionen and 1 other locations)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedDecember 31, 2027
Study endsSeptember 30, 2028
Registry record updatedSeptember 15, 2026
Trial IDNCT06823622 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are literate, Swedish-speaking adolescents aged 15 and older with asthma or those who have undergone a solid organ transplantation.

Probably not a fit

Patients who are not literate or do not speak Swedish may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The STEPSTONES project in Sweden aims to evaluate a person-centered transition program for adolescents with chronic conditions, specifically asthma and those who have undergone solid organ transplants. This innovative digital adaptation, Digi-STEPSTONES, seeks to improve accessibility and continuity of care by delivering the transition program remotely. The study will compare the effectiveness of this digital approach to traditional in-person care, focusing on outcomes such as patient empowerment, transition readiness, and quality of life. Additionally, it will explore the implementation and scalability of this digital model across various chronic conditions.

Why it matters

Potential benefit: If successful, this program could significantly enhance the transition experience for teenagers with chronic conditions, leading to better health management and quality of life.

How similar studies have gone: Previous studies have shown success with similar transition programs, indicating a promising approach to improving care for adolescents with chronic conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Participants:

Arm A - Literate and Swedish-speaking adolescents with asthma/allergy or went through a solid organ transplantation aged minimum 15 years. Their parents will be asked to fill out one questionnaire (proxy).

Arm B:

\- Literate and Swedish-speaking adolescents with asthma/allergy or went through a solid organ transplantation aged minimum 15 years. Their parents will be asked to fill out one questionnaire (proxy).

Sample size calculation:

Arm A: approximately100 patients will be recruited consecutively. Arm B: the approximate sample for individuals who received the intervention in-person is of

Where it's running

  • Queen Silvia Childrens hospital, Sahlgrenska university hospital
    Gothenburg, Vastra Gotalandsregionen, Sweden
    Recruiting
  • Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg
    Gothenburg, Sweden
    Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • In-situ vs Ex-situ Liver Preservation for Transplants

    This trial tests whether in-situ aNRP preservation works better than ex-situ DHOPE (with or without COR-NMP) for livers from donors after circulatory death in people awaiting liver transplantation.

    Recruiting at 2 sites Leiden University Medical Center · Groningen and 2 other locations · NCT07899853

  • N-WATCH: Can a simple breath device help monitor asthma in kids

    This study tests the N-Tidal C device to see if it helps monitor asthma in children aged 5 to under 16 who have wheeze or asthma and are not critically ill.

    Recruiting at 2 sites University of Nottingham · Nottingham, Nottinghamshire and 1 other locations · NCT07833826

  • Smart Inhaler Use at Home for Adolescents with IDD and Asthma

    This study tests whether daily use of active smart inhalers at home helps adolescents with intellectual disabilities manage asthma better.

    Recruiting Children's Hospital Los Angeles · Los Angeles, California · NCT07746921

  • ASMact: Managing bronchial asthma attacks in children

    This study tries a GINA 2025-based staff education and care-standardization approach to see if emergency treatment for children aged 6–17 with acute asthma attacks improves outcomes.

    Recruiting at 2 sites Meyer Children's Hospital IRCCS · Ferrara, FE and 1 other locations · NCT07412769

  • Biomarkers and Respiratory Omics in Children: Predicting Disease Course

    This study tests whether biomarkers from the lungs and blood can predict how asthma and protracted bacterial bronchitis in children will progress and respond to current therapies.

    Recruiting Medical University of Warsaw · Warsaw · NCT07232550

  • Using technology and school–clinic coordination to improve asthma care for children.

    This project will try a tech-enabled program plus school care coordination to help children ages 4–12 with persistent or uncontrolled asthma follow guideline-based treatment and have fewer symptoms and school problems.

    Recruiting Montefiore Medical Center · The Bronx, New York · NCT07224061

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.